ArticleClinical and translational medicine2021
Aptamer-SH2 superbinder-based targeted therapy for pancreatic ductal adenocarcinoma.
An-Dong Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it